Previous 10 | Next 10 |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In GoodRx To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 5, 2024) - Faruqi & Faruqi, LLP, a leading national secu...
2024-05-01 14:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of GoodRx Holdings, Inc. (NASDAQ: GDRX)? Did you purchase your shares between September 23, 2020 and November 8, 2022, inclusive? Did you lose money in your invest...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In GoodRx To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 28, 2024) - Faruqi & Faruqi, LLP, a leading national s...
Do you, or did you, own shares of GoodRx Holdings, Inc. (NASDAQ: GDRX)? Did you purchase your shares between September 23, 2020 and November 8, 2022, inclusive? Did you lose money in your investment in GoodRx Holdings, Inc.? Do you want to discuss your rights? NEW YORK, NY / A...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00...
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)? Did you purchase your shares between September 23, 2020 and November 8, 2022, inclusive? Did you lose money in your investment in GoodRx Holdings...
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired GoodRx Holdings, In...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx manageme...
2024-04-10 14:00:03 ET Scott Schoenhaus from BOCOM International Holdings Company issued a price target of $9.00 for GDRX on 2024-04-10 12:10:00. The adjusted price target was set to $9.00. At the time of the announcement, GDRX was trading at $6.92. The overall price tar...
News, Short Squeeze, Breakout and More Instantly...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® PR Newswire First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and S...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...
Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...